Literature DB >> 3484547

Barbiturates reduce human cerebral glucose metabolism.

W H Theodore, G DiChiro, R Margolin, D Fishbein, R J Porter, R A Brooks.   

Abstract

We studied the effect of barbiturates on local cerebral glucose metabolism by performing positron emission scans before and after withdrawal of phenobarbital or primidone. The postwithdrawal scan showed a significant increase (mean, 37%) in seven of eight cortical regions tested. Patients who had serial scans without a drug change showed a nonsignificant tendency for metabolic rates to go down on the second scan (mean decrease, 7%). Addition or deletion of a single drug other than barbiturate did not change metabolic rates on repeat scans. The depression in cerebral glucose metabolic rate due to phenobarbital, if confirmed, may have bearing on the adverse neuropsychological effects of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484547     DOI: 10.1212/wnl.36.1.60

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Regional cerebral blood flow by SPECT imaging in Sturge-Weber disease: an aid for diagnosis.

Authors:  C Chiron; C Raynaud; N Tzourio; C Diebler; O Dulac; M Zilbovicius; A Syrota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 4.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

5.  Early single photon emission computed tomography in Sturge-Weber syndrome.

Authors:  F Pinton; C Chiron; O Enjolras; J Motte; A Syrota; O Dulac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

6.  Normal cerebral FDG uptake during childhood.

Authors:  Kevin London; Robert Howman-Giles
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-10       Impact factor: 9.236

7.  Single photon emission computed tomography in seizure disorders.

Authors:  R Denays; M Rubinstein; H Ham; A Piepsz; P Noël
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

8.  Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

Authors:  P Maquet; D Dive; E Salmon; R von Frenckel; G Franck
Journal:  Eur J Nucl Med       Date:  1990

9.  Interictal regional cerebral blood flow during non specific activation test in partial epilepsy.

Authors:  J Valmier; J Touchon; M Baldy-Moulinier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

10.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.